Some U.S. drugmakers still see benefit of being in vaccine business

10/29/2004 |

Despite recent shortages of flu vaccine, some pharmaceutical manufacturers believe making vaccines is still a good business. Several U.S. drugmakers are actively developing new vaccines for diseases ranging from infections obtained in kidney dialysis centers to viruses that cause ebola, West Nile and SARS to pneumococcal-caused diseases.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA